Latest News about Preclinical Phase
Recent news which mentions Preclinical Phase
PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
February 14, 2022
Tickers
PMCB
From Benzinga
ImmunoPrecise's COVID-19 Antibody Cocktail Shows Neutralization Activity Against Omicron
January 31, 2022
Tickers
IPA
From Benzinga
IDEAYA Advances IDE161 Into IND-Enabling Studies, Exercises Licensing Option For PARG Inhibitors
January 31, 2022
Tickers
IDYA
From Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
From Benzinga
HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo
January 20, 2022
Tickers
HCWB
From Benzinga
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
January 12, 2022
Tickers
HTBX
From Benzinga
EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action
January 11, 2022
From Benzinga
Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine
January 04, 2022
From Benzinga
BiondVax Shares Skyrocket After It Plans To In-License Nanosized COVID-19 Antibody
December 22, 2021
Tickers
BVXV
From Benzinga
Aridis Stock Rallies After Positive Preclinical Data For COVID-19 Antibody Against Omicron
December 21, 2021
Tickers
ARDS
From Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
From Benzinga
iTeos Posts New Preclinical Data For Anti-TIGIT Antibody At ASH 2021
December 10, 2021
Tickers
ITOS
From Benzinga
Anixa Biosciences Says COVID-19 Compounds Potentially Effective Against Omicron Variant
December 07, 2021
Tickers
ANIX
From Benzinga
From Benzinga
Codiak's COVID-19 Vaccine Hopeful Shows Potential In Preclinical Study
December 02, 2021
Tickers
CDAK
From Benzinga
Why Are Qualigen Therapeutics Shares Surging During Premarket Tuesday?
November 23, 2021
Tickers
QLGN
From Benzinga
RegenXbio's Duchenne Gene Therapy Secures FDA Orphan Drug Tag
November 22, 2021
Tickers
RGNX
From Benzinga
Voyager Therapeutics's Cancer Antibody Program Shows Encouraging Preclinical Action
November 19, 2021
Tickers
VYGR
From Benzinga
Armata Shares Surge As FDA Gives Green Signal To Its Second Program To Enter Human Trial(s)
November 18, 2021
Tickers
ARMP
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
